Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03805919
What this trial is testing

Men at High Genetic Risk for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 500
Not applicableUnknownNCT05787145
What this trial is testing

ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment

Who this might be right for
Prostatic NeoplasmsPsychological DistressPhysician-Patient Relations+4 more
Ciusss de L'Est de l'Île de Montréal 300
Not applicableEnrolling By InvitationNCT00102544
What this trial is testing

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Who this might be right for
AdenocarcinomaProstate NeoplasmsProstate Cancer+2 more
National Institutes of Health Clinical Center (CC) 3,894
Not applicableNot Yet RecruitingNCT06662708
What this trial is testing

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

Who this might be right for
Prostate CancerProstate Intraductal CarcinomaProstate Cancer Aggressiveness+2 more
Shao Pengfei 200
Testing effectiveness (Phase 2)Looking for participantsNCT05919264
What this trial is testing

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerColorectal CancerSolid Tumor+12 more
Parabilis Medicines, Inc. 619
Testing effectiveness (Phase 2)Study completedNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 20
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Testing effectiveness (Phase 2)Study completedNCT00006101
What this trial is testing

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Who this might be right for
Prostate Cancer
Thomas E. Ahlering 76
Not applicableStudy completedNCT05384002
What this trial is testing

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Recurrent+1 more
Fondazione del Piemonte per l'Oncologia 14,000
Not applicableNot Yet RecruitingNCT07618520
What this trial is testing

Expanding Genetic Access for Prostate Cancer Survivors

Who this might be right for
Prostate Cancer PatientsHereditary CancerGenetic Testing
Georgetown University 500
Not applicableStudy completedNCT04353973
What this trial is testing

Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine 256
Testing effectiveness (Phase 2)Ended earlyNCT04926181
What this trial is testing

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Who this might be right for
Small Cell Neuroendocrine CarcinomaProstate CancerSmall Cell Carcinoma
Rahul Aggarwal 2
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528
What this trial is testing

PTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Looking for participantsNCT05888532
What this trial is testing

64Cu-GRIP B in Patients With Advanced Malignancies

Who this might be right for
Prostate CancerRenal CancerUrethral Cancer+3 more
Rahul Aggarwal 91
Post-approval studies (Phase 4)UnknownNCT06144099
What this trial is testing

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery

Who this might be right for
Prostate CancerSpine, OpenHip Osteoarthritis+1 more
Konkuk University Medical Center 154
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Early research (Phase 1)Study completedNCT04470843
What this trial is testing

Impact of Acetazolamide in Reducing Referred Postoperative Pain

Who this might be right for
Prostate CancerMen
Medical College of Wisconsin 33
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Early research (Phase 1)Ended earlyNCT04586335
What this trial is testing

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Who this might be right for
Ovarian CancerBreast CancerSolid Tumor+2 more
Haihe Biopharma Co., Ltd. 24
Next Page